| Literature DB >> 35663637 |
Marilia Sa Carvalho1, Leonardo Soares Bastos1, Trevon Fuller2, Owaldo Gonçalves Cruz1, Luana Damasceno2, Guilherme Calvet2, Paola Cristina Resende3, Chris Smith4, Jimmy Whitworth4, Marilda Siqueira3, Patricia Brasil2.
Abstract
Background: Incidence rates of SARS-CoV-2 infections in low-resource communities can inform vaccination strategies and non-pharmaceutical interventions (NPIs). Our objective was to estimate incidence over four epidemic waves in a slum in Rio de Janeiro, a proxy for economically deprived areas in the Global South.Entities:
Keywords: COVID-19; Household transmission; Incidence density
Year: 2022 PMID: 35663637 PMCID: PMC9135359 DOI: 10.1016/j.lana.2022.100283
Source DB: PubMed Journal: Lancet Reg Health Am ISSN: 2667-193X
Sociodemographic and virologic characteristics of the study participants (N = 2501). IQR = interquartile range.
| Variable | Overall, | B.1.1.44, | Zeta, | Gamma, | Delta, |
|---|---|---|---|---|---|
| Median age in years (IQR) | 21 (8-37) | 19 (5-37) | 25 (8-37) | 22 (9-38) | 17 (8-34) |
| Age categories | N (%) | N (%) | N (%) | N (%) | N (%) |
| 0 to 4 years | 408 (16%) | 191 (22%) | 79 (15%) | 79 (12%) | 59 (13%) |
| 5 to 11 years | 503 (20%) | 167 (19%) | 96 (19%) | 126 (20%) | 114 (25%) |
| 12 to 17 years | 250 (10.0%) | 74 (8.4%) | 37 (7.1%) | 76 (12%) | 63 (14%) |
| 18 to 59 years | 1192 (48%) | 397 (45%) | 268 (52%) | 326 (51%) | 201 (44%) |
| 60 and older | 148 (5.9%) | 55 (6.2%) | 38 (7.3%) | 37 (5.7%) | 18 (4.0%) |
| Female | 1512 (60%) | 544 (62%) | 308 (59%) | 379 (59%) | 281 (62%) |
| SARS-COV-2 positive by RT-PCR | 744 (12%) | 139 (12%) | 200 (17%) | 287 (14%) | 118 (7%) |
| SARS-CoV-2 seropositive | 1479 (34%) | 339 (33%) | 199 (21%) | 318 (21%) | 623 (73%) |
Figure 1Virologic and immunological outcomes for each cohort participant. The at-risk period for each individual in the cohort is represented by a horizontal grey line, beginning on the date of recruitment. The lines are stacked on top of each other to form the diagonal curve. The vertical dashed lines represent the end of one wave and the beginning of the next wave, as described in the Methods section. The dots represent each participant's RT-PCR results, positive serology results (colours described in the legend), and the date when each person received the first vaccine dose.
Figure 2Stringency of Non-pharmaceutical Interventions (NPIs) by SARS-CoV-2 waves. The black line shows the Stringency Index. The period of dominance of each lineage is depicted in different shades of grey. The dates marking the beginning and end of each wave are shown on the x-axis. The start of vaccination by age group is also indicated. The period analysed in this article is demarcated by dashed lines.
Figure 3Vaccine coverage by age group in the city of Rio de Janeiro during the study. The dates on the x-axis show the beginning of vaccination in each age group. The grey areas indicate the period of predominance of each Sars-CoV-2 lineage.
Figure 4Association between age and the number of persons per room and the risk of being a SARS-CoV-2 case (odds ratios +/- credible intervals) by wave.
Figure 5Incidence density by age group in each epidemic wave.